Etanidazole is a nitroimidazole drug that was investigated in clinical trials for its radiosensitizing properties in cancer treatment.

Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase.

[1][2] The result is that tissues become more sensitive to the ionizing radiation.

This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.